Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | KLK7 | P49862 | 1/20 | 0.33 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | SMYD2 | Q9NRG4 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30424461 | 1.00 | CYP3A4 (0.33) | CYP3A4HTTSMN1; SMN2MAPTKLK7 | |
| SCHEMBL4784364 | 0.88 | ALDH1A1 (0.39) | CYP3A4HTTSMN1; SMN2MAPTRIPK1 | |
| SCHEMBL4784371 | 0.88 | ALDH1A1 (0.39) | CYP3A4HTTSMN1; SMN2MAPTRIPK1 | |
| SCHEMBL3754571 | 0.87 | MAPT (0.38) | CYP3A4HTTSMN1; SMN2MAPTTSHR | |
| SCHEMBL1926988 | 0.84 | KMT2A (0.41) | ATML3MBTL1 | |
| SCHEMBL1927300 | 0.84 | KMT2A (0.41) | ATML3MBTL1 | |
| SCHEMBL1487233 | 0.84 | KMT2A (0.41) | ATML3MBTL1 | |
| SCHEMBL6683815 | 0.83 | ACP3 (0.35) | CYP3A4HTTSMN1; SMN2 | |
| SCHEMBL3850698 | 0.82 | CYP3A4 (0.33) | CYP3A4HTTSMN1; SMN2RIPK1SMYD2 | |
| SCHEMBL3852052 | 0.82 | CYP3A4 (0.33) | CYP3A4HTTSMN1; SMN2RIPK1SMYD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116390727-A | N-linked isoquinolinamides as LRRK2 inhibitors, pharmaceutical compositions and uses thereof | 默沙东有限责任公司 | 2023-07-04 | — | — | CN | disclosed |